- Home
- MRNA vs PARAA Comparison
MRNA vs PARAA Comparison
Compare MRNA & PARAA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MRNA
- PARAA
- Stock Information
- Founded
- MRNA 2010
- PARAA 1986
- Country
- MRNA United States
- PARAA United States
- Employees
- MRNA N/A
- PARAA N/A
- Industry
- MRNA Biotechnology: Biological Products (No Diagnostic Substances)
- PARAA Broadcasting
- Sector
- MRNA Health Care
- PARAA Industrials
- Exchange
- MRNA Nasdaq
- PARAA Nasdaq
- Market Cap
- MRNA 16.0B
- PARAA 15.2B
- IPO Year
- MRNA 2018
- PARAA N/A
- Fundamental
- Price
- MRNA $24.72
- PARAA $22.17
- Analyst Decision
- MRNA Hold
- PARAA Sell
- Analyst Count
- MRNA 20
- PARAA 15
- Target Price
- MRNA $54.47
- PARAA $11.75
- AVG Volume (30 Days)
- MRNA 10.2M
- PARAA 24.8K
- Earning Date
- MRNA 05-01-2025
- PARAA 05-08-2025
- Dividend Yield
- MRNA N/A
- PARAA 0.90%
- EPS Growth
- MRNA N/A
- PARAA N/A
- EPS
- MRNA N/A
- PARAA N/A
- Revenue
- MRNA $3,236,000,000.00
- PARAA $29,213,000,000.00
- Revenue This Year
- MRNA N/A
- PARAA $0.21
- Revenue Next Year
- MRNA $22.07
- PARAA $1.18
- P/E Ratio
- MRNA N/A
- PARAA N/A
- Revenue Growth
- MRNA N/A
- PARAA N/A
- 52 Week Low
- MRNA $23.15
- PARAA $16.59
- 52 Week High
- MRNA $170.47
- PARAA $26.34
- Technical
- Relative Strength Index (RSI)
- MRNA 36.68
- PARAA 40.66
- Support Level
- MRNA $23.68
- PARAA $22.03
- Resistance Level
- MRNA $27.21
- PARAA $22.85
- Average True Range (ATR)
- MRNA 2.06
- PARAA 0.52
- MACD
- MRNA -0.03
- PARAA -0.04
- Stochastic Oscillator
- MRNA 26.98
- PARAA 52.80
About MRNA Moderna Inc.
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 40 mRNA development candidates in clinical development as of September 2024. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.
About PARAA Paramount Global
Paramount Global operates in three global business segments: TV media, filmed entertainment, and direct to consumer. The TV media business includes television production studios and various broadcast and cable networks, including CBS, 15 owned CBS affiliates, Paramount, Nickelodeon, MTV, BET, and VH1. Filmed entertainment consists multiple film studios, most importantly Paramount Pictures. The film studios produce and distribute movies that they license to movie theaters and other media outlets. Direct to consumer includes the Paramount+, Pluto TV, and BET+ streaming services. Much of the content on Paramount's streaming platforms is created by the production studios housed within the firm's other two business segments.